Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Lexicon Initiates Phase 2 Clinical Trial Of LX2931 In Patients With Rheumatoid Arthritis
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced that it has initiated a Phase 2 clinical trial of LX2931 in patients with rheumatoid arthritis. LX2931 is an orally-delivered, small molecule drug candidate that has recently completed Phase 1 testing in normal volunteers. Lexicon also successfully completed a drug-drug interaction (DDI) study of LX2931 with methotrexate in patients with rheumatoid arthritis, with no clinically significant drug-drug interactions observed.

Reports From The White House And Kaiser Family Foundation Address Health Care Disparities
Health and Human Services Secretary Kathleen Sebelius and White House Health Czar Nancy Ann DeParle held a discussion of minority health issues at the White House yesterday, where Sebelius "said the Obama administration is committed to addressing the "alarming disparity in the delivery of quality health care"," which she said was necessary to lower costs, the Associated Press reports. The White House also "issued a summary report on minority health care showing that African-Americans are seven times more likely as whites to have HIV/AIDS, that blacks and Hispanics have diabetes rates nearly twice as high as whites, and that black men are 50 percent more likely than whites to have prostate cancer" (Evans, 6/9).
News of the day
BrainGate2: Brain-Computer Interface Begins New Clinical Trial For Paralysis
Scientists at the Massachusetts General Hospital (MGH) have initiated the BrainGate2 pilot clinical trial to expand restorative neurotechnology research for some patients with paralysis. This trial expands on previous research that explores methods that may help paralyzed patients control assistive technologies.
Mental Health

Florida-Based Organization Encourages Black Women To Be Tested For HIV

The one-year-old Florida-based organization Sistas Organizing to Survive on Saturday held a rally in Orlando that sought to raise awareness of HIV among black women and encourage them to be tested, the Orlando Sentinel reports. According to Debbie Tucci, coordinator for the Orange County Health Department"s HIV/AIDS program, one in 68 black women in the state is living with HIV/AIDS and many are unaware they are infected. AIDS has been a leading cause of death for black women ages 25 to 44 in the state for the past 15 years, the Sentinel reports (Ruano Gonzç¡lez, Orlando Sentinel, 6/21). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009